project id: TCGA-UCEC; case submitter id: TCGA-AJ-A4ZG; sample id: e8625cb2-1502-4174-9adc-e9bde7e483fe; sample submitter id: TCGA-AJ-A4ZG-01A; portion id: c2f91170-ee04-489f-ba94-3776da97a333; portion submitter id: TCGA-AJ-A4ZG-01A-11; analyte id: b2d9a594-5294-403f-b48e-6c1f7f90e472; analyte submitter id: TCGA-AJ-A4ZG-01A-11D; aliquot id: b650b7c1-c608-4f29-928e-ab5d342e992c; aliquot submitter id: TCGA-AJ-A4ZG-01A-01D-YYYY-23; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 53; days to birth: -19492; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1959; age at diagnosis: 19492; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 498.0; figo stage: Stage IVB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 57; days to sample procurement: 0; specimen type: Solid Tissue; percent monocyte infiltration: 20.0;